Note: Dewpoint Therapeutics's revenues are gauged from an analysis of company filings.
Dewpoint Therapeutics's Income Statement (based on Industry Averages)
Dewpoint Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Dewpoint Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
February 4, 2022
18
100%
$150 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Dewpoint Therapeutics is developing and marketing.
Dewpoint Therapeutics doesn't have any recent trademark applications, indicating Dewpoint Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
DEWPOINT THERAPEUTICS Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use; Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; Scientific, biological, pharmaceutical and medical research services; Laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug discovery and drug development services; Biological research and development services; Scientific condensate-based research in the field of drug discovery and drug development; online, non-downloadable computer software using artificial intelligence for use in the fields of scientific research and drug discovery; Downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
03/03/2023
D Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use; Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; Scientific, biological, pharmaceutical and medical research services; Laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug discovery and drug development services; Biological research and development services; Scientific condensate-based research in the field of drug discovery and drug development; online, non-downloadable computer software using artificial intelligence for use in the fields of scientific research and drug discovery; Downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
03/03/2023
D DEWPOINT THERAPEUTICS Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use; Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; Scientific, biological, pharmaceutical and medical research services; Laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug discovery and drug development services; Biological research and development services; Scientific condensate-based research in the field of drug discovery and drug development; online, non-downloadable computer software using artificial intelligence for use in the fields of scientific research and drug discovery; Downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
03/03/2023
See all trademarks and details in the Full Report.
Market Share of Dewpoint Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Dewpoint Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Dewpoint Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Dewpoint Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.